Literature DB >> 19489017

Comparison of MRI signatures in pattern I and II multiple sclerosis models.

Sébastien Serres1, Daniel C Anthony, Yanyan Jiang, Sandra J Campbell, Kerry A Broom, Alexandre Khrapitchev, Nicola R Sibson.   

Abstract

The majority of individuals with multiple sclerosis (MS) exhibit T-cell- and macrophage-dominated lesions (patterns I and II; as opposed to III and IV). These lesions, in turn, may be distinguished on the basis of whether or not there are immunoglobulin and complement depositions at the sites of active myelin destruction; such depositions are found exclusively in pattern II lesions. The main aim of this study was to determine whether pattern I and pattern II MS lesions exhibit distinct MRI signatures. We have used a recently described focal MOG-induced EAE model of the rat brain, which recapitulates many of the hallmarks of pattern II MS; we compared this with our previous work in a delayed type hypersensitivity model of a pattern I type lesion in the rat brain. Demyelinating lesions with extensive inflammation were generated, in which the T2-weighted signal was increased. Magnetisation transfer ratio (MTR) maps revealed loss and subsequent incomplete recovery of the structure of the corpus callosum, together with changes in tissue water diffusion and an associated increase in ventricle size. Notably, the MTR changes preceeded histological demyelination and may report on the processes leading to demyelination, rather than demyelination per se. Immunohistochemically, these MRI-detectable signal changes correlated with both inflammatory cell infiltration and later loss of myelin. Breakdown of the blood-brain barrier and an increase in the regional cerebral blood volume were also evident in and around the lesion site at the early stage of the disease. Interestingly, however, the MRI signal changes in this pattern II type MS lesion were remarkably consistent with those previously observed in a pattern I lesion. These findings suggest that the observed signal changes reflect the convergent histopathology of the two models rather than the underlying mechanisms of the disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19489017     DOI: 10.1002/nbm.1404

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  19 in total

Review 1.  Spontaneous ocular and neurologic deficits in transgenic mouse models of multiple sclerosis and noninvasive investigative modalities: a review.

Authors:  Archana A Gupta; Di Ding; Richard K Lee; Robert B Levy; Sanjoy K Bhattacharya
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-13       Impact factor: 4.799

2.  Structural abnormalities in the thalamus of migraineurs with aura: a multiparametric study at 3 T.

Authors:  Cristina Granziera; Alessandro Daducci; David Romascano; Alexis Roche; Gunther Helms; Gunnar Krueger; Nouchine Hadjikhani
Journal:  Hum Brain Mapp       Date:  2013-03-01       Impact factor: 5.038

Review 3.  Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

Authors:  Djordje Miljković; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2013-04-22       Impact factor: 8.401

4.  Magnetic resonance imaging reveals therapeutic effects of interferon-beta on cytokine-induced reactivation of rat model of multiple sclerosis.

Authors:  Sébastien Serres; Claire Bristow; Rocío M de Pablos; Doron Merkler; Manuel Sarmiento Soto; Nicola R Sibson; Daniel C Anthony
Journal:  J Cereb Blood Flow Metab       Date:  2013-02-20       Impact factor: 6.200

5.  T₂-weighted MRI detects presymptomatic pathology in the SOD1 mouse model of ALS.

Authors:  Matthew C Evans; Sébastien Serres; Alexandre A Khrapitchev; Helen B Stolp; Daniel C Anthony; Kevin Talbot; Martin R Turner; Nicola R Sibson
Journal:  J Cereb Blood Flow Metab       Date:  2014-02-05       Impact factor: 6.200

6.  Anti-CD20 inhibits T cell-mediated pathology and microgliosis in the rat brain.

Authors:  Daniel C Anthony; Alex M Dickens; Nicholas Seneca; Yvonne Couch; Sandra Campbell; Begona Checa; Veerle Kersemans; Edward A Warren; Matthew Tredwell; Nicola R Sibson; Veronique Gouverneur; David Leppert
Journal:  Ann Clin Transl Neurol       Date:  2014-09-16       Impact factor: 4.511

7.  Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.

Authors:  Shannon Kolind; Arshia Seddigh; Anna Combes; Bretta Russell-Schulz; Roger Tam; Vignan Yogendrakumar; Sean Deoni; Naomi A Sibtain; Anthony Traboulsee; Steven C R Williams; Gareth J Barker; Peter A Brex
Journal:  Neuroimage Clin       Date:  2015-10-03       Impact factor: 4.881

8.  The contribution of the acute phase response to the pathogenesis of relapse in chronic-relapsing experimental autoimmune encephalitis models of multiple sclerosis.

Authors:  Silvy Mardiguian; Emma Ladds; Roberta Turner; Hazel Shepherd; Sandra J Campbell; Daniel C Anthony
Journal:  J Neuroinflammation       Date:  2017-09-30       Impact factor: 8.322

9.  Vascular adhesion protein-1 is actively involved in the development of inflammatory lesions in rat models of multiple sclerosis.

Authors:  Petri Elo; Sina Tadayon; Heidi Liljenbäck; Jarmo Teuho; Meeri Käkelä; Kalle Koskensalo; Virva Saunavaara; Jenni Virta; Tibor Z Veres; Aida Kiviniemi; Antti Saraste; Päivi Marjamäki; Laura Airas; Sirpa Jalkanen; Anne Roivainen
Journal:  J Neuroinflammation       Date:  2018-05-01       Impact factor: 8.322

10.  Peripheral Inflammation Enhances Microglia Response and Nigral Dopaminergic Cell Death in an in vivo MPTP Model of Parkinson's Disease.

Authors:  Irene García-Domínguez; Karolina Veselá; Juan García-Revilla; Alejandro Carrillo-Jiménez; María Angustias Roca-Ceballos; Marti Santiago; Rocío M de Pablos; José L Venero
Journal:  Front Cell Neurosci       Date:  2018-11-06       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.